Background and Aims: The neurological control of bladder function and the ability to be dry at night involves not only the acquisition of normal daytime control, but also the establishment of a circadian rhythm in vasopressin release and the ability to arouse to a full bladder during sleep. We postulated that in some children there might be a delay in maturation of the normal neurological pathways involved in establishment of nocturnal continence and examined this by using a specific neuropsychological test. Methods: Children attending an established nocturnal enuresis clinic were examined using the ReyOsterrieth test to assess the presence or absence of boundary errors in both copy and memory reproductions. The results of the test were scored independently and blind to the response to treatment with the vasopressin analogue DDAVP. Results: A significant association was found between boundary type errors and response to DDAVP, with non-responders making significantly more errors. No child with three or more errors responded to DDAVP. Using this test, the ability to predict response to treatment was 70%. Conclusions: It is postulated that the Rey-Osterrieth test, through the presence or absence of boundary errors, reflects a delay in maturation and/or a disorganisation of the retinal-hypothalamic-cortical pathways in the brain. The association previously described with growth hormone neurosecretory dysfunction syndrome would be compatible with this.
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T he mechanisms underlying the normal postnatal development of bladder control are not fully understood. It is clear, however, that the central nervous system must play a role in converting the process from a reflex action into one that is under voluntary control. A delay in this process has been postulated as a cause of nocturnal enuresis in some children. 1 Butler and Holland have summarised factors involved in the aetiology of nocturnal enuresis into a three systems model suggesting that the treatment of nocturnal enuresis requires an understanding of these three components: a failure to produce vasopressin at night, bladder instability, and a failure to wake to a full bladder. 2 Each component of the three systems may be influenced by endogenous or exogenous factors. Therefore to obtain night time continence it not only requires an intact neurological pathway as for daytime continence, but the ability to develop a circadian release of vasopressin at night and to wake from sleep if urine production exceeds bladder capacity. The aetiological factors described above suggest that a disorder in the neurological pathway at any point in the visual-hypothalamic-pituitary axis and the locus coerulus and bladder could result in enuresis.
The Rey-Osterrieth figure test ( fig 1) is a neuropsychological test devised in 1941 by Andre Rey and used in children by Osterrieth in 1946. It has been widely used in the neuropsychological and clinical psychological assessment of children, and allows assessment of a variety of cognitive processes, including planning and organisational skills and problem solving strategies, as well as perceptual, motor, and memory functions. Waber and Holmes studied children's reproduction of the Rey-Osterrieth figure and determined the developmental change children make in both copying and recalling the figure.
3 Andronikoff-Sanglade et al, using this test, noted that specific, previously unrecognised boundary type errors, were highly concordant (p < 0.0005) with the growth hormone neurosecretory dysfunction syndrome. 4 These are children who have normal growth hormone response to specific stimulation tests but have low endogenous nocturnal secretion.
5 These boundary type errors described by Andronikoff-Sanglade et al are not featured as part of the normal developmental changes and were a coincidental finding when studying children with short stature. These errors were unrelated to developmental or intelligence quotient.
We postulated that some children with nocturnal enuresis might have similar findings with a neuronal developmental abnormality affecting the visual-hypothalamic-pituitary axis. The study therefore examined children with nocturnal enuresis comparing those responsive and unresponsive to treatment with the vasopressin analogue DDAVP.
METHODS
Children were recruited from an established nocturnal enuresis clinic run at Leeds General Infirmary. They were entered into the study if they fulfilled the following criteria: 7 years or over with primary monosymptomatic nocturnal enuresis and on average greater than four wet nights per week; in fulltime education with no statement of educational need; no known neurological or urological problem; and gave informed consent. Two groups of children were entered: a retrospective group, who were already on treatment, and a prospective group, who were recruited during the study.
The Rey-Osterrieth figure test was administered in two parts. Firstly the child was asked to copy the figure on a blank piece of paper the same size as the model. As each section was finished, the child was handed a different coloured pencil and a note made of the colour sequence. There is no time limit for completion. Once finished both the figure and the child's reproduction were removed from sight and approximately three minutes spent talking about unrelated issues. The child was then asked to draw the figure from memory onto a same size blank sheet of paper using a pencil with no colour change. The child is not forewarned of the task.
The figures were scored on the basis of the boundary type errors first described by Andronikoff-Sanglade and qualitative analysis of the Rey-Osterrieth figure was performed using three cut off points (table 1). One author (SB) completed the scoring after each child was allocated a random number. The author was, consequently, blind to which child was being One author (PH), who was blind to the results of the psychological test, determined the child's response to treatment with DDAVP. Success was defined as more than 10 out of 14 nights on average dry, representing at least an 80% improvement in dry nights.
RESULTS
A total of 34 children were recruited to the study, 15 in the retrospective group and 19 in the prospective group. Table 2 gives details of each group. The groups differed only in terms of age, although there was no significant difference in terms of boundary type errors (Mann-Whitney test, z = −1.21, p = 0.226). The two groups were consequently combined for analysis. Although there was a significant difference between ages in the responders (12.3 years) and non-responders (10.0 years) (Mann-Whitney z = −2.43, p = 0.015), there was no significant association between age and overall number of boundary errors (Spearman r = -0.264, p = 0.13). There was no significant difference in age between those who fell above or below the three cut off points, outlined in table 1. Mean ages below and above "cut off point 1" were 11.6 and 10.8 years (Mann-Whitney z = −0.78, p = 0.44), "point 2" 11.7 and 10.3 years (z = −1.43, p = 0.15), and "point 3" 11.7 and 9.7 years (z = −1.93, p = 0.054).
A significant association was found between boundary type errors and response to DDAVP, with non-responders making significantly more errors (Mann-Whitney test, z = −2.99, p = 0.003). In both copy and memory task, 11 children (32% of 34) studied made no errors at all, four (12%) made one error, eight (24%) made two errors, and 11 (32%) made three or more errors. In copy reproduction, only 18 (53% of 34) made no error, nine (26%) made one error, four (12%) two errors, and three (9%) made three or more errors. Highly significant differences were found between responders and nonresponders using these cut off points (table 3) . No child with three or more errors responded to DDAVP. Table 4 shows the ability to predict response to treatment. 
DISCUSSION
Andronikof-Sanglade made a chance observation during routine assessment of children with growth hormone neurosecretory dysfunction syndrome, noting specific boundary type errors on the Rey-Osterrieth test. This test is independent of development (age) or intelligence and has been validated by Andronikof-Sanglade. We postulated that this test may reflect delayed development in the neuronal pathways related to the midbrain and hypothalamic-pituitary axis, and therefore may be abnormal in children with primary enuresis. In children with nocturnal enuresis we showed that those children unresponsive to DDAVP had a highly significant increase in boundary type errors, independent of growth.
Jarvelin has reported that children with poor linear growth were more likely to have nocturnal enuresis. Devitt et al, using a generalised linear model analysis, showed that the shorter Figure 2 Copy reproduction of the Rey-Osterrieth figure by a 12 year old boy who made no boundary type errors and responded to DDAVP. 
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